![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Ocular Therapeutix Taking Aim at Allergy Market (OIS: Ophthalmology Innovation Source) View |
![]() |
Ocular Therapeutix - OIS@ASCRS2015 (OIS: Ophthalmology Innovation Source) View |
![]() |
Ocular Therapeutix - OIS@AAO 2015 (OIS: Ophthalmology Innovation Source) View |
![]() |
Ocular Therapeutix to Refile Dextenza NDA (OIS: Ophthalmology Innovation Source) View |
![]() |
Clinical Progress of Ocular Therapeutix’s Dextenza (OIS: Ophthalmology Innovation Source) View |
![]() |
Ocular Therapeutix - Glaucoma Breakout at OIS @ AAO 2019 (OIS: Ophthalmology Innovation Source) View |
![]() |
Ocular Therapeutix Waiting for Word from FDA (OIS: Ophthalmology Innovation Source) View |
![]() |
Glaucoma: Chasing a better treatment with Ocular Therapeutix's Amar Sawhney | Disruptors (MassDevice) View |
![]() |
Allergy Therapeutics Investor Update (Five Minute Pitch TV) View |
![]() |
Cynthia Matossian, MD, FACS interviewed by Jonathan Kahn, MD at ASCRS 2015 Resure (Cynthia Matossian, MD, FACS) View |